SHAH NIKITA (Executive Vice President) sold 47.4% of their position (131.86K shares) of AMNEAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.57M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Class A Common Stock
Shares
+36.33K
Price / share
$2.75
Trade value
$99.91K
% of position
Class A Common Stock
Shares
+95.53K
Price / share
$2.75
Trade value
$262.69K
% of position
Class A Common Stock
Shares
−131.86K
Price / share
$11.92
Trade value
$1.57M
% of position
Net shares
+0.00
Net value
-$1.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 11/12/2025 | M · Option Exercise | +36.33K | $2.75 | $99.91K | 24.8% | 146.40K | 182.73K |
| Class A Common Stock Direct | 11/12/2025 | M · Option Exercise | +95.53K | $2.75 | $262.69K | 52.3% | 182.73K | 278.26K |
| Class A Common Stock Direct | 11/12/2025 | S · Sale | −131.86K | $11.92 | $1.57M | 47.4% | 278.26K | 146.40K |
| Total | +0.00 | -$1.21M | ||||||
Stock Option (Right to Buy)
Class A Common Stock
36.33K shares
Shares
−36.33K
Strike price
2.75
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Class A Common Stock
95.53K shares
Shares
−95.53K
Strike price
2.75
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock36.33K shares | 11/12/2025 | M · Option Exercise | −36.33K | 2.75 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Class A Common Stock95.53K shares | 11/12/2025 | M · Option Exercise | −95.53K | 2.75 | — | 0.00 |